IDEXX Labs (NASDAQ: IDXX) reported Q2 EPS of $4.27, $0.31 better than the analyst estimate of $3.96. Revenue for the quarter came in at $1.22 billion versus the consensus estimate of $1.2 billion.

GUIDANCE:

IDEXX Labs sees FY2026 EPS of $14.69-$14.94, versus the consensus of $14.66. IDEXX Labs sees FY2026 revenue of $4.7-4.75 billion, versus the consensus of $4.71 billion.

For earnings history and earnings-related data on IDEXX Labs (IDXX) click here.